BioAge Labs, Inc.
BIOA
$4.13
-$0.07-1.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -71.05M | -71.11M | -70.94M | -62.16M | -65.76M |
| Total Depreciation and Amortization | 171.00K | 167.00K | 161.00K | 171.00K | 162.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.32M | 8.24M | 13.77M | 17.08M | 20.21M |
| Change in Net Operating Assets | 8.34M | 11.18M | 2.12M | -2.82M | 2.36M |
| Cash from Operations | -53.21M | -51.52M | -54.89M | -47.72M | -43.03M |
| Capital Expenditure | -792.00K | -366.00K | -340.00K | -134.00K | -155.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -77.56M | -- | 0.00 | 0.00 | 0.00 |
| Cash from Investing | -78.35M | -366.00K | -340.00K | -134.00K | -155.00K |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 12.50M |
| Total Debt Repaid | -6.00M | -6.00M | -5.50M | -4.00M | -2.50M |
| Issuance of Common Stock | 222.25M | 222.25M | 194.61M | 429.00K | 7.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 542.00K | 170.54M | 170.54M | 170.00M | 170.00M |
| Repurchase of Preferred Stock | -40.00K | -40.00K | -40.00K | -40.00K | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.05M | -5.56M | -4.33M | -1.83M | -561.00K |
| Cash from Financing | 211.70M | 381.20M | 355.29M | 164.56M | 179.45M |
| Foreign Exchange rate Adjustments | 50.00K | 81.00K | -121.00K | -28.00K | 31.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.18M | 329.39M | 299.94M | 116.68M | 136.29M |